On the cover: Representative sections show immunochemistry for nitrotyrosine (X630) in plaques of patients without morning blood pressure surge (MBPS) peak (MP-) and patients with MBPS peak (MP+). Similar regions of plaque are shown. Results are typical of MP-, MP+ carvedilol-treated, and MP+ metroprolol-treated plaques. (See page 787.)